There is no explicit legal requirement for a company’s board of directors to include members with medical or pharmaceutical backgrounds. The applicant is the corporate entity, and the regulator’s core requirement is that the company engages qualified key technical personnel, such as a Responsible Person (RP), registered pharmacist and Authorised Person (AP), who are responsible for and supervise licensed activities. However, from the perspective of corporate governance and risk management, having a board member with a relevant professional background is undoubtedly an advantage. It signals to the regulator that the company’s senior decision-makers can understand and assess the risks specific to the pharmaceutical industry and are better placed to support and oversee the company’s compliant operations.
HONG KONG DRUG LICENSING
Must any member of the board of directors of a company applying for a pharmaceutical licence have a medical or pharmaceutical background?
A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.
Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.
Back to Category C: Applicant Eligibility and Personnel Requirements (Q101-Q150) Search more questions